Tykerb (lapatinib ditosylate tablets – Novartis, generic) — Cigna
Bone cancer (recurrent chordoma)
Initial criteria
- Patient age ≥ 18 years
- Patient has recurrent chordoma
- Patient has epidermal growth factor receptor (EGFR)-positive disease
Approval duration
1 year